Patents Assigned to HARMONIC PHARMA
  • Derivatives of cephalosporin for treating cancer
    Patent number: 10821114
    Abstract: The present invention relates to a new class of cephalosporin derivatives of formula (I), notably having CXCR4 receptor antagonist effect, useful as a therapeutic agent for treating cancer, in particular for treating breast cancer, lung cancer and uveal melanoma. The invention further relates to a pharmaceutical composition comprising a compound of formula (I) and an additional antitumor drug for treating cancer.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: November 3, 2020
    Assignees: INSTITUT CURIE, HARMONIC PHARMA
    Inventors: Arnaud Sinan Karaboga, Violeta Isabel Perez-Nueno, Michel Souchet, Didier Decaudin